EDNRA and ovarian carcinoma: Of clinical relevance, ETAR is expressed in 85 % of ovarian cancer and is preferentially co-expression with β-arr in the advanced tumors, further revealing the pathophysiological role of β-arr1 and ET-1R in tumor progression [28].